Drug Type AAV based gene therapy |
Synonyms ANB004 Biocad, ANB 004 - Biocad |
Target |
Action modulators |
Mechanism survival of motor neuron 1, telomeric modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HMN (Hereditary Motor Neuropathy) Proximal Type I | Phase 2 | Belarus | 02 Feb 2023 | |
| HMN (Hereditary Motor Neuropathy) Proximal Type I | Phase 2 | Russia | 02 Feb 2023 |





